Puma Biotechnology Inc Cash Flow Quality Index
Puma Biotechnology Inc cash flow quality index. Puma Biotechnology Inc (PBYI) has a Cash Flow Quality Index of 1.22x as of December 2025. Operating cash flow of $14.42 Million exceeds net income of $11.80 Million, indicating high earnings quality where cash backs reported profits. Explore PBYI operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Puma Biotechnology Inc (2022–2025)
Cash flow quality index of Puma Biotechnology Inc from 2022 to 2025. Historical Cash Flow Quality Index for Puma Biotechnology Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Puma Biotechnology Inc (PBYI) balance sheet quality index to measure how much of total assets are equity-financed.
Puma Biotechnology Inc Cash Flow Quality Index by Year (2022–2025)
Puma Biotechnology Inc cash flow quality index by year from 2022 to 2025. Year-by-year earnings quality comparison for Puma Biotechnology Inc. For the full cash flow conversion analysis, see Puma Biotechnology Inc (PBYI) cash conversion ratio.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | $41.80 Million | $31.11 Million | ▲ +4.5% |
| 2024 | 1.29x | $38.92 Million | $30.28 Million | ▲ +2.8% |
| 2023 | 1.25x | $27.01 Million | $21.59 Million | ▲ +100.0% |
| 2022 | -7913.50x | $-15.83 Million | $2.00K | — |